NSAID use linked to reduced risk of skin cancer

This article originally appeared here.
NSAID Use Linked to Reduced Risk of Skin Cancer
NSAID Use Linked to Reduced Risk of Skin Cancer

(HealthDay News) -- Nonsteroidal anti-inflammatory drugs (NSAIDs), including nonselective NSAIDs and older cyclooxygenase (COX)-2 inhibitors, are associated with a decreased risk of squamous cell carcinoma (SCC) and malignant melanoma (MM), particularly among long-term and high-intensity NSAID users, according to a study published online May 29 in Cancer.

Sigrun Alba Johannesdottir, from the Aarhus University Hospital in Denmark, and colleagues analyzed all 1,974 incident cases of SCC, 13,316 incident cases of basal cell carcinoma (BCC), and 3,242 incident cases of MM in northern Denmark from 1991 to 2009. Approximately 178,655 controls were age-, gender-, and county of residence-matched to the cases. A prescription database was used to ascertain drug usage.

The researchers found that, overall, ever use (more than two prescriptions) of NSAIDs was associated with a decreased risk of SCC (incidence rate ratio [IRR], 0.85) and MM (IRR, 0.87). Higher intensity use (>25 percent prescription coverage during the total duration of use) and long-term use (at least seven years) strengthened the association. NSAID use did not correlate with an overall reduced risk of BCC (IRR, 0.97; 95 percent confidence interval, 0.93 to 1.01), but there was a significantly reduced risk of BCC at sites other than the head and neck with long-term use (IRR, 0.85) and high-intensity use (IRR, 0.79). Use of nonselective NSAIDs and older COX-2 inhibitors (diclofenac, etodolac, and meloxicam) primarily drove the reduced risk.

"The current results indicated that NSAID use may decrease the risk of SCC and MM," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs